Rocket Pharmaceuticals Inc (RCKT) — Long-term Investment Intensity
Rocket Pharmaceuticals Inc (RCKT) has a Long-term Investment Intensity of 6.1% as of December 2023. Long-term investments of $34.32 Million represent 6.1% of total assets of $566.34 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Rocket Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Rocket Pharmaceuticals Inc Long-term Investment Intensity (2018–2023)
This chart shows how Rocket Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2018 to 2023. As of December 2023, the intensity stands at 6.1%, reflecting long-term investments of $34.32 Million against total assets of $566.34 Million USD. Explore Rocket Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Rocket Pharmaceuticals Inc (2018–2023)
The table below presents the year-by-year Long-term Investment Intensity for Rocket Pharmaceuticals Inc from 2018 to 2023, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Rocket Pharmaceuticals Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 6.1% | $34.32 Million | $566.34 Million | ▼ -1.8 pp |
| 2022 | 7.8% | $43.28 Million | $551.81 Million | ▲ +4.9 pp |
| 2018 | 2.9% | $7.40 Million | $251.31 Million | — |